✦ LIBER ✦

Assessing immunogenicity of biosimilar therapeutic monoclonal antibodies: regulatory and bioanalytical considerations

✍ Scribed by Chamberlain, Paul

Book ID: 120003186
Publisher: Future Science
Year: 2013
Tongue: English
Weight: 684 KB
Volume: 5
Category: Article
ISSN: 1757-6180
DOI: 10.4155/bio.13.6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of Antibody-Based Therapeuti

Development of Antibody-Based Therapeutics || Bioanalytical Considerations for Development of Antibody-Based Therapeutics: Pharmacokinetics and Immunogenicity

✍ Tabrizi, Mohammad A.; Bornstein, Gadi G.; Klakamp, Scott L. 📂 Article 📅 2012 🏛 Springer New York ⚖ 515 KB

Handbook of Therapeutic Antibodies (Dübe

Handbook of Therapeutic Antibodies (Dübel/Handbook of Therapeutic Antibodies) || Regulatory Considerations in the Development of Monoclonal Antibodies for Diagnosis and Therapy*

✍ Dübel, Stefan; Reichert, Janice M. 📂 Article 📅 2014 🏛 Wiley-VCH Verlag GmbH & Co. KGaA 🌐 German ⚖ 167 KB

Practical Considerations for the Pharmac

Practical Considerations for the Pharmacokinetic and Immunogenic Assessment of Antibody–Drug Conjugates

✍ Sauerborn, Melody; van Dongen, William 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 973 KB

Statistical and Bioanalytical Considerat

Statistical and Bioanalytical Considerations for Establishing a Depletion Criterion for Specificity Testing During Immunogenicity Assessment of a Biotherapeutic

✍ Driscoll, R. O.; Zhou, L.; Moxness, M.; Mytych, D.; Chirmule, N.; Jawa, V. 📂 Article 📅 2013 🏛 American Association of Pharmaceutical Scientists 🌐 English ⚖ 311 KB